What phase of research do you need help with?
Select from USC, CHLA or LAC DHS
Select from a range of services
Get early access to treatment options and help advance research for cancer and other diseases.
Want to give back to research? Learn how to become a reviewer.
Yvonne Lin-Liu, MD, MS
Evaluation of epigenetic drugs as potential therapeutic agents for ARID1A-deficient ovarian clear cell carcinoma (OCCC)
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.